In this issue:
Fibrinolysis for intermediate-risk PE
PE thrombolysis and mortality/ haemorrhage
Anticoagulation ±CDT for lower-extremity proximal DVT
Bleeding risk with NSAIDs/aspirin in acute VTE
Asthma increases PE risk
Drug therapies for PAH
Echocardiography of the pulmonary circulation and RV function
Causes of pulmonary hypertension in the elderly
Tadalafil in COPD
Sildenafil and melanoma risk in men
Outcomes of acute VTE treatment
Clinical deterioration after PE
Please login below to download this issue (PDF)